Health ❯ Healthcare ❯ Cancer Research

Clinical Trials

Patient Outcomes Preclinical Studies Targeted Therapy Therapeutic Innovations Survival Rates Drug Development Phase 3 Trials Precision Medicine Retrospective Studies NHS Galleri Trial RAS Mutations Surveillance Programs Genetic Testing Public Involvement Guideline Development KRAS Protein Funding Sources ALASCCA Study Treatment Efficacy Innovative Diagnostics Prostate Cancer Studies Phase II Trials Mouse Models Surgical Oncology Proof-of-Concept Trials Metastasis Prevention Immunotherapy Approaches Treatment Resistance Molecular Testing TRANSFORM Trial Treatment Options Immunotherapy Saliva Tests for Cancer Olaparib Nivolumab Immunotherapy Research Patient Monitoring Innovative Treatments Funding Impact Study Results Randomized Controlled Trials Targeted Therapies Funding and Support Therapeutic Development Therapeutic Vaccines Patient Representation COMET Study American Society of Clinical Oncology Treatment Strategies Phase III Trials Drug Efficacy Preclinical Research Early Detection Adaptive Trial Designs Patient Disparities Observational Studies Experimental Studies Patient Support Preclinical Models Self-Sampling Immunotherapy Development Cell Therapy Azenosertib Density MATTERS Trial HERMES Study Aspirin Treatment FDA Approvals ATOMIC Study Bispecific CAR T Cells Dietary Interventions

Engineered CAR T Cells Targeting MUC16 Control Bladder Tumors in Mice

Direct catheter delivery confined the engineered cells to the bladder, thereby reducing off-target spread, paving the way for clinical testing.

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

Penn Study Finds About 30% Lower Breast Cancer Incidence Among Women Prescribed GLP‑1 Drugs

Two-Session MRI-Guided Radiotherapy Matches Five Visits on Side Effects in Small Prostate Cancer Trial

UCSF-Led Study Engineers CAR-T Cells In Vivo, Clearing Tumors in Mice

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

Swedish Study Ties Lower Ipilimumab Dose to Longer Survival and Less Toxicity in Advanced Melanoma

ECOG-ACRIN Review Finds Black AML Patients Have Worse Survival Independent of Cytogenetics

AACR Releases First Pediatric Cancer Progress Report, Citing Record Survival and Persistent Gaps

Targeted Nanoparticles Help Checkpoint Drugs Erase Ovarian Tumors in Mice

Lobular Breast Cancer Is Rising Fast, Now Over 1 in 10 U.S. Cases

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

Adding Molecular Breast Imaging to 3D Mammography Boosts Cancer Detection in Dense Breasts, Major Trial Finds

Low-Dose Aspirin Halves Recurrence in PI3K-Altered Colorectal Cancer, NEJM Trial Finds

AACR’s 2025 Report Shows Cancer Survival Gains as Early-Onset Cases Climb, Presses for Sustained U.S. Funding

Study Finds Extrachromosomal DNA Can Emerge Before Tumors in Glioblastoma

Repurposed Drugs Clear Dormant Breast Cancer Cells in Phase II Trial

Blood Microbial DNA Classifier Accurately Distinguishes Primary Liver Cancer From Colorectal Metastases

EGFR Inhibitors Show Promise Against Immunotherapy-Resistant NF1-Mutant Melanoma